The surgical issue questionnaire was reviewed for potential causes of the reported issue.The clinical representative did not notice the expiration date and (b)(4) was opened to investigate the expired product being implanted.A representative conducted a review of sterilization and packaging records for the respective product lot; it has been confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.The stimulator is used to treat pain.The cause of implanting an expired product is due to the clinical representative providing the clinician with an expired trial stimulator (user error - clinical representative).Refer to (b)(4) for investigation details, including risk assessment of implanting an expired stimulator.
|
An expired freedom scs neurostimulator trial lead was implanted.The product was shipped to the clinical representative on june 18, 2021, expired on march 01, 2023 and was implanted on (b)(6) 2023.The lead pull was performed as expected on (b)(6) 2023.The patient had a successful trial with no adverse events reported, and will be moving forward with a permanent implant.
|